tiprankstipranks
Armata Pharmaceuticals Inc (ARMP)
:ARMP
US Market
ARMP
Armata Pharmaceuticals
RESEARCH TOOLSreports
Want to see ARMP full AI Analyst Report?

Armata Pharmaceuticals (ARMP) Income Statement

299 Followers

Armata Pharmaceuticals Income Statement

Last quarter (Q4 2025), Armata Pharmaceuticals's total revenue was $1.08M, a decrease of -12.15% from the same quarter last year. In Q4, Armata Pharmaceuticals's net income was $-124.30M. See Armata Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 4.90M$ 5.17M$ 4.53M$ 5.51M$ 4.47M
Gross Profit
$ 3.37M$ -29.25M$ 3.56M$ -29.51M$ -15.54M
Operating Expenses
$ 34.59M$ 13.18M$ 44.45M$ 7.44M$ 8.28M
Depreciation and Amortization
$ 1.53M$ 1.32M$ 972.00K$ 892.00K$ 1.17M
EBITDA
$ -29.69M$ -41.11M$ -65.45M$ -36.05M$ -21.92M
Operating Income
$ -31.22M$ -42.44M$ -40.89M$ -36.95M$ -23.82M
Other Income/Expenses
$ -142.58M$ 23.52M$ -28.16M$ 29.00K$ 667.00K
Pretax Income
$ -173.80M$ -18.92M$ -69.05M$ -36.92M$ -23.16M
Net Income
$ -173.80M$ -18.92M$ -69.05M$ -36.92M$ -23.16M
Per Share Metrics
Basic EPS
$ -4.80$ -0.52$ -1.91$ -1.08$ -0.96
Diluted EPS
$ -4.80$ -0.52$ -1.91$ -1.08$ -0.96
Weighted Average Shares Outstanding
 36.24M 36.16M 36.08M 34.29M 24.10M
Weighted Average Shares Outstanding (Diluted)
 36.24M 36.16M 36.08M 34.29M 24.10M
Currency in USD

Armata Pharmaceuticals Earnings and Revenue History